Fortress Biotech Inc. (FBIOP)
5.20
0.12 (2.36%)
At close: Apr 15, 2025, 3:58 PM
5.22
0.38%
After-hours: Apr 15, 2025, 04:01 PM EDT
2.36% (1D)
| Bid | 4.83 |
| Market Cap | 47.46M |
| Revenue (ttm) | 57.67M |
| Net Income (ttm) | -48.31M |
| EPS (ttm) | -0.863 |
| PE Ratio (ttm) | -6.03 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 5.24 |
| Volume | 33,383 |
| Avg. Volume (20D) | 11,685 |
| Open | 5.05 |
| Previous Close | 5.08 |
| Day's Range | 4.72 - 5.20 |
| 52-Week Range | 4.72 - 17.45 |
| Beta | 1.83 |
About FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 14, 2017
Employees 101
Stock Exchange NASDAQ
Ticker Symbol FBIOP
Website https://www.fortressbiotech.com
